Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Pharmaceutical and Biomedical Analysis"
DOI: 10.1016/j.jpba.2018.05.028
Abstract: ABSTRACT Sofosbuvir (SOF) and daclatasvir (DCS) are novel, recently developed direct acting antiviral agents characterized by potent anti‐hepatitis C virus action. A fast and efficient HPLC‐UV method was developed, validated and applied for simultaneous determination…
read more here.
Keywords:
hepatitis;
sofosbuvir daclatasvir;
method;
sof ... See more keywords